Skip to Content
You are currently on the new version of our website. Access the old version .

Diseases

Diseases is an international, peer-reviewed, open access, multidisciplinary journal with focus on research on human diseases and conditions, published monthly online by MDPI. 

Indexed in PubMed | Quartile Ranking JCR - Q2 (Medicine, Research and Experimental)

All Articles (1,565)

Background: Pulmonary inflammation is a widely recognized characteristic of active tuberculosis (TB). Although standard TB treatment is effective, a substantial proportion of mycobacteriologically cured TB patients experience persistent pulmonary inflammation, which can lead to long-term lung impairment, post-tuberculosis lung disease (PTLD) and potentially TB recurrence. Methods: We conducted a case–control study to compare host serum biomarker profiles in individuals with minimal (TLG < 50 SUVbw*mL, n = 37) versus extensive (TLG ≥ 50 SUVbw*mL, n = 34) persistent lung inflammation following completion of standard drug-sensitive TB treatment. Lung inflammation was measured by 18F-FDG PET/CT scan using total lung glycolysis (TLG) as a surrogate marker. All participants had negative sputum cultures at four months of TB treatment, and blood samples were collected at treatment completion (month six). A Luminex® multiplex assay performed on the Bio-Plex® 200 platform was used to analyze 48 host serum biomarkers involved in cytokine/chemokine signaling. Results: Following multiple t-test analysis, fifteen biomarkers were significantly elevated (p < 0.05) in participants with extensive persistent lung inflammation compared to those with minimal inflammation. Among these, 14 demonstrated potential as discriminatory markers, with area under the curve (AUC) values ranging from 0.707 to 0.806, sensitivities ranging from 47.06% to 73.53%, and specificities ranging from 70.27% to 83.78%. Notably, 13 of these 16 candidate biomarkers significantly correlated with TLG values, further supporting their potential clinical utility. Conclusion: We report associations between serum inflammatory mediators and persistent pulmonary inflammation following mycobacterial clearance in TB patients, highlighting their potential as diagnostic biomarkers that could potentially meet the target product profile (TPP) criteria.

12 February 2026

Representative PET/CT images of participants who successfully completed a 6-month drug-sensitive anti-TB treatment, showing the lung in coronal view (left) and lateral view (right). (A) Participant with extensive persistent lung inflammation (TLG ≥ 50 SUVbw*mL) and (B) Participant with minimal lung inflammation (TLG &lt; 50 SUVbw*mL).

Burden and Clinical Impact of Hepatitis D Virus Co-Infection Among HBsAg-Positive Patients in Mauritania

  • Mohamed Abdawa,
  • Mohamed Hemeyine and
  • Mohamed Vall Mohamed Abdellahi
  • + 2 authors

Background: Hepatitis B virus (HBV) infection remains highly endemic in sub-Saharan Africa, where hepatitis delta virus (HDV) co-infection substantially worsens liver disease outcomes. Mauritania has long been suspected to be a high-burden setting for HBV-HDV co-infection, yet contemporary data describing its clinical and virological impact remain limited. Methods: We conducted a hospital-based cross-sectional study at the National Institute of Hepato-Virology (INHV) in Nouakchott, including 401 HBsAg-positive patients. Demographic, clinical, biological, and virological data were collected. HDV serology and RNA testing were performed when available. Liver disease severity, including cirrhosis and hepatocellular carcinoma (HCC), was assessed using clinical, biological, and imaging criteria. Results: HDV antibodies were detected in 31.9% of HBsAg-positive patients, confirming Mauritania as a hyper-endemic area for HDV. HDV co-infection was strongly associated with advanced liver disease, with HDV antibodies present in 86.4% of cirrhotic patients and 82.4% of those with HCC. Patients with HDV infection frequently exhibited suppressed HBV DNA levels, reflecting viral interference. A substantial proportion of patients presented with decompensated cirrhosis or HCC at diagnosis, and nearly 70% were treatment-naïve. Overall, HDV co-infection emerged as the principal driver of severe liver disease in this cohort. Conclusions: HBV/HDV co-infection is highly prevalent in Mauritania and is associated with a wide clinical spectrum ranging from asymptomatic infection to decompensated cirrhosis and hepatocellular carcinoma. HDV co-infection is the principal driver of severe liver disease, often occurring despite low or undetectable HBV DNA levels. Systematic HDV screening among all HBsAg-positive individuals is urgently needed to improve risk stratification, guide therapeutic decisions, and reduce liver-related morbidity and mortality.

12 February 2026

Pharmacological Management of Delirium in Older Adults in the Emergency Department: Clinical Outcomes

  • Angela Soler-Sanchis,
  • Francisco Miguel Martínez-Arnau and
  • Pilar Pérez-Ros

Background/Objectives: Delirium is frequent and serious in older adults attending the emergency department (ED), but evidence on its pharmacological management in this setting is limited. This study aimed to quantify the pharmacological treatment of delirium in older adults in the ED and examine its association with subsequent hospital admission. Methods: A cross-sectional study was conducted between November 2021 and June 2022 in a Spanish ED. The sample included 153 adults aged 65 years or older with clinician-diagnosed delirium. Clinical, triage, and medication data were obtained from electronic medical records, and associations with hospital admission were analysed using multivariable logistic regression. Results: Ninety-one participants (59.5%) were hospitalised. Antipsychotic, analgesic, and benzodiazepine use was associated with hospitalisation. Absence of an underlying cause was a protective factor. The logistic regression model was significant. Conclusions: By identifying the most frequently administered pharmacological treatments for delirium in older adults in the ED and describing their association with hospitalisation, this study provides key insights into real-world clinical practice patterns in this setting.

12 February 2026

Background/Objectives: Perinatal depression and anxiety are significant mental health concerns, and pharmacological treatments often pose considerable challenges. Therefore, this study aimed to evaluate the mental health status of pregnant and postpartum women and identify the factors affecting perinatal depression and anxiety. Methods: This cross-sectional study included 286 pregnant and postpartum women who completed questionnaires, including the Patient Health Questionnaire-9 (PHQ-9), Korean Version of the Edinburgh Postnatal Depression Scale (K-EPDS), and Generalized Anxiety Disorder-7 (GAD-7). Results: Symptoms of depression and anxiety were prevalent among participants. PHQ-9-positive cases were significantly less frequent in women from nuclear families, and their Pregnancy Stress Scale scores were significantly higher. K-EPDS-positive women had significantly lower rates of wanted pregnancies and marital satisfaction. GAD-7-positive cases showed significantly lower rates of wanted pregnancies, lower levels of social support, and higher Pregnancy Stress Scale scores. Conclusions: These findings highlight key psychosocial factors associated with perinatal depression and anxiety among pregnant and postpartum women, underscoring the importance of comprehensive mental health assessment during the perinatal period.

11 February 2026

News & Conferences

Issues

Open for Submission

Editor's Choice

Reprints of Collections

Inflammation
Reprint

Inflammation

The Cause of all Diseases 2.0
Editors: Vasso Apostolopoulos, Jack Feehan, Vivek P. Chavda
Inflammation: The Cause of All Diseases
Reprint

Inflammation: The Cause of All Diseases

Editors: Vasso Apostolopoulos, Jack Feehan, Vivek P. Chavda

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Diseases - ISSN 2079-9721